A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision ...
Some AI models designed to predict stroke and diabetes risk may be based on datasets whose origins cannot be verified, ...
This research assesses data provenance in widely used health datasets, revealing flaws that could undermine clinical prediction models and patient care.
Meta CEO Mark Zuckerberg has directed staff to build a prediction markets platform, a source confirmed to CNBC. The New York Times was first to report the app's development. Stocks of sports gambling ...
Continuous glucose monitoring (CGM) has become a cornerstone of care for many people with diabetes who use insulin, providing real-time glucose data that can guide treatment decisions and help reduce ...
Researchers developed ALADYNOULLI, a Bayesian generative model that combines longitudinal health records, age, and polygenic ...
Mark Zuckerberg’s Meta is quietly developing a prediction markets app that could challenge industry leaders Polymarket and Kalshi, according to a report. Zuckerberg recently tasked a small team inside ...
The experimental app, internally called “Arena,” would be independent of Facebook and Instagram. It could compete for attention with Polymarket and Kalshi, the biggest prediction markets. By Mike ...
NCAA president Charlie Baker says they're willing to work with the Commodity Futures Trading Commission to develop a system that protects student-athletes and consumers from harm. Kevin Dietsch / ...
Clinical trial evidence reviewed by an independent NICE committee shows that teplizumab can delay the onset of symptomatic type 1 diabetes by an average of nearly 3 years. Teplizumab is the ...
The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales. Teplizumab is a form of immunotherapy that can give people three extra years before ...